Cardura XL Pfizer Inc. - Treatment for Benign Prostatic Hyperplasia (BPH)
Cardura XL is an extended release formulation providing a
controlled release of doxazosin over a 24-hour period. Cardura XL
is indicated for the treatment of the signs and symptoms of benign
prostatic hyperplasia (BPH). Cardura XL is not indicated for the
treatment of hypertension.
Posted: February 2005
Cardura XL (doxazosin mesylate) FDA Approval History